Brief: Sciclone Pharmaceuticals Says Sciclone And Menarini Establish License And Collaboration Deal
07/11/2023 24:58
Nov 7 (Reuters) - SciClone Pharmaceuticals (Holdings)
Ltd 6600.HK :
* SCICLONE AND MENARINI ESTABLISH LICENSE AND COLLABORATION
AGREEMENT FOR ORSERDU IN CHINA
* AGREEMENT GRANTING GROUP EXCLUSIVE RIGHT TO DEVELOP AND
COMMERCIALIZE ORSERDU IN CHINA
Further company coverage: 6600.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SciClone Pharmaceuticals (Holdings)
See all newsOneRobotics surges on plan to buy more shares
Brief: Onerobotics (Shenzhen) To Procure Affiliate Of Co To Acquire 59.9% Stake Of Nanoleaf Limited, Others
Brief: OneRobotics (Shenzhen) Says Final Offer Price Under Global Offering Is HK$73.80 Per H Share
Brief: Sciclone Pharmaceuticals (Holdings) Announces Proposal For Privatisation Of Co By Silver Pegasus Investment
Brief: SciClone Pharmaceuticals Says Trading In Shares Halted